当前位置:首页 - 行情中心 - 昭衍新药(603127) - 财务分析

昭衍新药

(603127)

  

流通市值:120.55亿  总市值:143.30亿
流通股本:6.30亿   总股本:7.49亿

昭衍新药(603127)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.41亿元,每股收益0.05元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益810920.59万元,未分配利润213608.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产942465.86万元,负债131545.27万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入287,337,235.012,018,333,771.811,335,156,050.4849,356,544.11
营业总成本288,252,886.211,763,748,341.311,227,734,251.03753,062,458.9
营业利润49,382,588.17104,347,309.12-69,661,013.72-177,154,741.3
利润总额49,383,749.8104,039,073.62-69,892,269.79-177,351,107.31
净利润41,119,465.2569,755,063.9-74,244,009.94-172,238,316.14
其他综合收益-766,939.36-51,041,084.41-4,859,185.753,024,917.86
综合收益总额40,352,525.8918,713,979.49-79,103,195.69-169,213,398.28
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计5,063,761,087.585,031,197,927.385,334,112,028.965,492,884,034.54
非流动资产合计4,360,897,521.944,364,954,683.074,191,072,779.024,168,389,654.14
资产总计9,424,658,609.529,396,152,610.459,525,184,807.989,661,273,688.68
流动负债合计1,097,659,363.431,110,568,596.281,298,706,870.561,518,194,812.49
非流动负债合计217,793,323.03206,395,760.21235,643,339.19227,837,447.75
负债合计1,315,452,686.461,316,964,356.491,534,350,209.751,746,032,260.24
归属于母公司股东权益合计8,108,836,282.88,078,818,586.728,002,435,682.27,916,012,413.2
股东权益合计8,109,205,923.068,079,188,253.967,990,834,598.237,915,241,428.44
负债和股东权益合计9,424,658,609.529,396,152,610.459,525,184,807.989,661,273,688.68
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计429,804,957.521,811,387,046.151,367,691,390.73919,139,371.69
经营活动现金流出小计364,655,756.361,472,458,327.751,175,365,681.39761,422,728.38
经营活动产生的现金流量净额65,149,201.16338,928,718.4192,325,709.34157,716,643.31
投资活动现金流入小计617,613,712.483,365,501,966.772,508,098,115.211,914,486,106.33
投资活动现金流出小计951,573,490.955,328,525,952.313,458,148,881.922,660,158,066.46
投资活动产生的现金流量净额-333,959,778.47-1,963,023,985.54-950,050,766.71-745,671,960.13
筹资活动现金流入小计----
筹资活动现金流出小计18,665,128.1265,627,486.97248,828,091.97107,250,255.99
筹资活动产生的现金流量净额-18,665,128.1-265,627,486.97-248,828,091.97-107,250,255.99
汇率变动对现金及现金等价物的影响-1,154,223.861,278,854.73-6,969,366.76-246,310.23
现金及现金等价物净增加额-288,629,929.27-1,888,443,899.38-1,013,522,516.1-695,451,883.04
期末现金及现金等价物余额676,571,156.45965,203,128.591,840,124,511.872,158,195,144.93
最新报告期:2025-05-11
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中泰证券崔少煜,祝嘉琦0.470.540.632025-05-11
国信证券彭思宇0.440.510.552025-05-09
华安证券谭国超0.290.360.412025-04-07
华西证券崔文亮,徐顺利0.500.480.502025-04-01
中金公司张琎,吴婉桦0.520.54--2025-04-01
TOP↑